Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_provenance.
• NP547764.RA6tC_8d-9irCHUxbm_UZRNq0mT4fkX86vgUsRZFvgRF0130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547764.RA6tC_8d-9irCHUxbm_UZRNq0mT4fkX86vgUsRZFvgRF0130_provenance.
• NP930679.RAnFPmjXVU_nxOpgmA4u3RljYurdlPlzVSvA5dDiSlHCM130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930679.RAnFPmjXVU_nxOpgmA4u3RljYurdlPlzVSvA5dDiSlHCM130_provenance.
• NP356989.RAJI-I76u7PfA95mpj6ieE97nGAsYVAYxF5hzxdG1y3f0130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356989.RAJI-I76u7PfA95mpj6ieE97nGAsYVAYxF5hzxdG1y3f0130_provenance.
• NP496342.RAFL8XE5cIMBjxVKDjSjHiVsbKlSsdymKN7hyrOZ-QlGk130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496342.RAFL8XE5cIMBjxVKDjSjHiVsbKlSsdymKN7hyrOZ-QlGk130_provenance.
• NP604483.RA7AZm_ufvVwozdnTT7y1adF2ND4uqPJZJaiNIk7wlKCU130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP604483.RA7AZm_ufvVwozdnTT7y1adF2ND4uqPJZJaiNIk7wlKCU130_provenance.
• NP848048.RAc3zq8isYpEzUEWmXvB6Q_3uOhkpQo8-ZGd037JBxMos130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848048.RAc3zq8isYpEzUEWmXvB6Q_3uOhkpQo8-ZGd037JBxMos130_provenance.
• NP964339.RAYHiV9sWB7x5IiFs6ZqfwfGWKYKNi7b8-5rxCMuptAIw130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964339.RAYHiV9sWB7x5IiFs6ZqfwfGWKYKNi7b8-5rxCMuptAIw130_provenance.
• NP848033.RA1EVhYf4j5RqVpHiMoS7NVBipTYsHrw9oN9fq7L-7NiE130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848033.RA1EVhYf4j5RqVpHiMoS7NVBipTYsHrw9oN9fq7L-7NiE130_provenance.
• NP964340.RA0R4kceVvlbROsIRlO6rEcfPuAGqoYa40k5q1VKtPpt0130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964340.RA0R4kceVvlbROsIRlO6rEcfPuAGqoYa40k5q1VKtPpt0130_provenance.
• NP1085521.RAUaB530jgxYVPIdEfwI0ZomuONIbiv3om-ichA76SIQk130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1085521.RAUaB530jgxYVPIdEfwI0ZomuONIbiv3om-ichA76SIQk130_provenance.
• NP1085524.RAZCdaSPAdoAupU80vWD889Zgyd-oVN90eFIW7cZD8p-0130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1085524.RAZCdaSPAdoAupU80vWD889Zgyd-oVN90eFIW7cZD8p-0130_provenance.
• NP1085525.RAbDgINOBm7IzHFRlDKpHG6J3OUBFIWiqSqMyjB6xaWH0130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1085525.RAbDgINOBm7IzHFRlDKpHG6J3OUBFIWiqSqMyjB6xaWH0130_provenance.
• NP1085527.RAbBA7c7tTaOAvKCVZiPT4eVqo_sps_oMElI4_V_aK8b8130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1085527.RAbBA7c7tTaOAvKCVZiPT4eVqo_sps_oMElI4_V_aK8b8130_provenance.
• NP1085528.RAQazZpwPEmyKGEREUhm2cjz8fXthtB-9cEDLqYIbK4sw130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1085528.RAQazZpwPEmyKGEREUhm2cjz8fXthtB-9cEDLqYIbK4sw130_provenance.
• assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP848024.RAH4AUAwVUiyLYiSOyCxStm3cFBizoSS_2LCqA1AyKQNY130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848024.RAH4AUAwVUiyLYiSOyCxStm3cFBizoSS_2LCqA1AyKQNY130_provenance.
• NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_provenance.
• NP1085526.RAjbTU1NInU1d6jzraJRp5OI9f1X1T9v2Cdp-1BjI7mNM130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1085526.RAjbTU1NInU1d6jzraJRp5OI9f1X1T9v2Cdp-1BjI7mNM130_provenance.